Hospitals & Clinics
-
Opportunity India Desk Jul 19, 2018 - 3 min readDaiichi Sankyo has approached the Delhi high court to block the $1 billion sale of Fortis Healthcare to Malaysian group IHH Bhd while it enforces an arbitration award against the former promoters of the Indian hospital chain. The high court issued notices on Wednesday to Fortis and its erstwhile promoters Malvinder and Shivinder Singh, seeking ... -
Opportunity India Desk Jul 18, 2018 - 3 min readMalaysian group IHH Healthcare Berhad’s Rs 40 billion acquisition of Fortis Healthcare is expected to result in improved cash flow, better operating profit margins and new business opportunity for the Indian hospital chain. Fortis, which has been under the regulatory scanner on charges of fund diversion, has seen its losses widen due to provisioning and ... -
Opportunity India Desk Jul 18, 2018 - 1 min readDrug firm Zydus Cadila Tuesday said it has received final approval from the US health regulator to market Clindamycin Phosphate Topical Solution, used to treat acne. The company has received approval from the US Food and Drug Administration (USFDA) to market Clindamycin Phosphate Topical Solution USP (Cleocin T), 1 per cent, Zydus Cadila said in ... -
Opportunity India Desk Jul 17, 2018 - 2 min readJiva Ayurveda launched first-of-its-kind diagnostic protocols for Ayurveda in the presence of Vaidya Rajesh Kotecha, Secretary, Ministry of AYUSH, Govt. of India, with the aim to create a definite structure for this ancient healing tradition and turn it into globally accepted medical science. Called Ayunique, the newly developed protocols are the result of a huge ... -
Opportunity India Desk Jul 12, 2018 - 2 min readAmar Ujala Group, India’s leading integrated media company formally announced its diversification into trustworthy and inclusive healthcare. Mr Probal Ghosal, Director, Amar Ujala commenting on this development said, “Amar Ujala is creating a modern healthcare brand based on the principles of awareness and social equity in Tier- 2 and Tier- 3 cities of India. The ... -
Opportunity India Desk Jul 12, 2018 - 2 min readPfizer Inc announced plans on Wednesday to reorganize into three units, separating its consumer healthcare business that the U.S. drugmaker has been trying to sell since last year. The company said it is still looking for options for the lower-margin, non-core consumer healthcare business that makes products ranging from painkiller Advil to lip balms and ... -
Opportunity India Desk Jul 07, 2018 - 1 min readDrug firm Zydus Cadila today said it has got tentative nod from the US health regulator to market Deferasirox tablets for oral suspension. "Zydus Cadila has received the tentative approval from USFDA to market Deferasirox Tablets for Oral Suspension (Exjade Tablets) in the strengths of 125 mg, 250 mg and 500 mg," the company said ... -
Opportunity India Desk Jul 07, 2018 - 2 min readTPG has pipped rival private equity investors to acquire a stake of slightly over 40% in Sai Life Sciences a Hyderabad-based provider of drug discovery, development and manufacturing services for around $135 million, or Rs 900 crore, people directly aware of the matter said. TPG will seal the deal through secondary share purchase from existing ... -
Opportunity India Desk Jul 06, 2018 - 1 min readGlenmark Pharma today said its subsidiary Glenmark Specialty has entered into an exclusive licensing agreement with Australia's Seqirus to commercialise its nasal spray Ryaltris in Australia and New Zealand. Ryaltris is indicated for treatment of symptoms associated with seasonal allergic rhinitis (SAR) in patients over 12 years of age. "Under the terms of the agreement, ... -
Opportunity India Desk Jul 05, 2018 - 2 min readWith about 7,000 Indian women participating in a World Health Organisation led study on heat-stable Carbetocin, the injectible drug is now set for registration with the Indian drug regulator for approvals to sell locally, said Suresh Pattathil, Chief Executive of Ferring Pharmaceuticals. Used to prevent excessive bleeding at birth, heat-stable Carbetocin is an alternative to ...
Share
Phone - Verified
Email - Verified
GST - Verified
In August 2019, Reliance Industries Limited (RIL) & BP, two powerful industry icons with a history of milestones to their...
Investment
Required 2 Cr - 5 Cr
Required 2 Cr - 5 Cr
Space Required
Urban (2000 sqmt onwards) - Highway (3600 sqmt onwards) Sq.ft
Locations for expansion
Delhi, Haryana, Punjab, +20
Phone - Verified
Email - Verified
GST - Verified
Lupin Diagnostics is a part of Lupin Healthcare Ltd, a 100% subsidiary of Lupin Limited...
Investment
Required 2 Lac - 5 Lac
Required 2 Lac - 5 Lac
Space Required
150 - 250 Sq.ft
Locations for expansion
Assam, Meghalaya, Mizoram +10
Phone - Verified
Email - Verified
GST - Verified
Our vision at Vedantu is to reimagine and evolve the way teaching and learning have been happening for decades...
Investment
Required 5 Lac - 10 Lac
Required 5 Lac - 10 Lac
Space Required
000 - 000 Sq.ft
Locations for expansion
Delhi, Haryana, Punjab, +20
Phone - Verified
Email - Verified
GST - Verified
Welcome to the world of Certified Castrol Auto Service workshops - a network of 4000+ workshops globally...
Investment
Required 5 Lac - 10 Lac
Required 5 Lac - 10 Lac
Space Required
3000 - 5000 Sq.ft
Locations for expansion
Delhi, Haryana, Punjab, +20
Phone - Verified
Email - Verified
GST - Verified
At UClean, we are building India's first organized chain of laundromats (laundry stores) focused on fostering...
Investment
Required 10 Lac - 20 Lac
Required 10 Lac - 20 Lac
Space Required
350 Sq.ft
Locations for expansion
Delhi, Haryana, Punjab, +20
Phone - Verified
Email - Verified
GST - Verified
The entire world is moving towards Hybrid working culture. The demand for Co-working/ Flexible office...
Investment
Required 2.5 Cr - 5 Cr
Required 2.5 Cr - 5 Cr
Space Required
8000 - 20000 Sq.ft
Locations for expansion
Delhi, Haryana, Punjab, +20
